Scanning for cancer treatment: Researchers combine CRISPR gene-editing technology with drug discovery to understand why treatment works (or doesn't)

Scanning for cancer treatment: Researchers combine CRISPR gene-editing technology with drug discovery to understand why treatment works (or doesn't)

11,000 people are predicted to die from acute myeloid leukemia (AML) in 2019. Recently, drug developers designed a new treatment to target the cancer's mutated genes. But, these drugs don't always work. Now, in a new study, researchers investigate both sides of the drug-body relationship to better understand why certain AML treatments -- and other cancer treatments -- may not work as expected.

  • 0 Likes

  • 0 Comments